Showing 168 results
-
Media Release /To help reduce the heavy burden of cardiovascular diseases (CVDs), Novartis launched the Unblocked movement for heart health – an initiative co-created with external stakeholders in the healthcare…
-
Media Release /Novartis Healthcare Philippines has been officially recognized by the Top Employers Institute as a Top Employer 2023 in the Philippines. To become recognized as a Top Employer, an organization…
-
Media Release /The ICanServe Foundation, City of Taguig, local healthcare software startup Dashlabs, and Novartis have launched the Circle of Life Data and Digital Infrastructure project to support the Ating…
-
Media Release /In a developing country like the Philippines, where healthcare delivery is mostly paid through patients' out-of-pocket expenses, the economic burden of heart failure (HF), especially…
-
Media Release /Novartis has made substantial contributions to support the Philippine economy and improve health outcomes of Filipinos. “We are committed to helping strengthen the Philippine economy. In 2021,…
-
Media Release /The Philippine Food and Drug Administration (FDA) has approved ribociclib for the treatment of metastatic breast cancer. Ribociclib in combination with an aromatase inhibitor or fulvestrant…
-
Story / -
Media Release /The Philippine Food and Drug Administration (FDA) has approved brolucizumab for the treatment of neovascular (wet) age-related macular degeneration (AMD). Wet AMD is the leading cause of severe…
-
Media Release /The APPIS Innovator Program enables patient organizations across Asia Pacific, Middle East and Africa (APMA) to grow and scale existing patient programs. Winners receive financial support,…
-
Media Release /Genetic mutations affect breast cancer prognosis, making every patient unique. It is important for patients to get tested to find out the specific mutation, and help doctors develop a personalized…
